UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study

Annals of oncology, 2016-06, Vol.27 (6), p.1020-1029

2016

Volltextzugriff (PDF)

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer

Human gene therapy, 2006-10, Vol.17 (10), p.1019-1026

2006

Volltextzugriff (PDF)

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

Annals of oncology, 2017-09, Vol.28, p.v375-v376

2017

Volltextzugriff (PDF)

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial

European journal of cancer (1990), 2012-03, Vol.48 (5), p.721-727

2012

Volltextzugriff (PDF)

Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapy

Oncology reports, 2013-01, Vol.29 (1), p.355-361

2013

Volltextzugriff (PDF)

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

Nature medicine, 2009-01, Vol.15 (1), p.68-74

2009

Volltextzugriff (PDF)

OC-0220 CHEMORADIOTHERAPY VS BIORADIOTHERAPY FOR LARYNX PRESERVATION: A GORTEC RANDOMIZED TRIAL (TREMPLIN)

Radiotherapy and oncology, 2012-05, Vol.103, p.S85-S85

2012

Volltextzugriff (PDF)

Basaloid squamous cell carcinoma of the head and neck: report of 18 cases

Journal of laryngology and otology, 2011-06, Vol.125 (6), p.608-613

2011

Volltextzugriff (PDF)

Elderly head and neck cancer (elan) study: Personalized treatment according to geriatric assessment in patients age 70 or older: First (SCCHN) unsuitable for surgery

Journal of geriatric oncology, 2014-10, Vol.5, p.S41-S41

2014

Volltextzugriff (PDF)

Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel

Annals of oncology, 2008-11, Vol.19 (11), p.1977-1978

2008

Volltextzugriff (PDF)

ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?

Journal of geriatric oncology, 2014-10, Vol.5, p.S28-S28

2014

Volltextzugriff (PDF)

Impact on autonomy of biweekly docetaxel as first-line chemotherapy (CT) regimen in elderly patients with metastatic breast cancer (MBC) – A FNCLCC Gerico Group Phase II multicentre trial

Critical reviews in oncology/hematology, 2008-10, Vol.68, p.S45-S45

2008

Volltextzugriff (PDF)

Doxorubin-based adjuvant chemotherapy for elderly patients with hormone receptors negative breast carcinoma: a French geriatric oncology group (GERICO) phase II multicentric program

Critical reviews in oncology/hematology, 2008-10, Vol.68, p.S24-S25

2008

Volltextzugriff (PDF)

Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness

British journal of cancer, 2003-04, Vol.88 (8), p.1207-1212

2003

Volltextzugriff (PDF)

1110O - Personalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials

Annals of oncology, 2019-10, Vol.30, p.v450-v450

2019

Volltextzugriff (PDF)

Personalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials

Annals of oncology, 2019-10, Vol.30, p.v450

2019

Volltextzugriff (PDF)

1110OPersonalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

Annals of oncology, 2017-07, Vol.28 (7), p.1612-1617

2017

Volltextzugriff (PDF)

Apigenin – strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo

Phytomedicine (Stuttgart), 2002-09, Vol.9 (6), p.489-495

2002

Volltextzugriff (PDF)

8518 Prognostic value of the expression of SDF 1 and CXCR 4 in head and neck squamous cell carcinoma (HNSCC)

European journal of cancer supplements, 2009, Vol.7 (2), p.476-476

2009

Volltextzugriff (PDF)

1331 Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): a feasibility study from the GEFCAPI

European journal of cancer supplements, 2009, Vol.7 (2), p.148-148

2009

Volltextzugriff (PDF)

Traffic Accidents and Their Recurrenece in at Risk Adolescents and Young Adults : Realities and Perspectives

Frontiers in psychology, 2017

2017

Volltextzugriff (PDF)

942TiPENCOURAGE: THE USE IN ROUTINE PRACTICE OF BEVACIZUMAB IN FIRST-LINE THERAPY FOR PATIENTS WITH OVARIAN CANCER– A GINECO PROSPECTIVE COHORT STUDY

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv336-iv325

2014

Volltextzugriff (PDF)

1 – 25 von 720

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(615)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(410)
Humans
(400)
Life Sciences & Biomedicine
(379)
Female
(241)
Male
(240)
Middle Aged
(199)
Adult
(178)
Biological And Medical Sciences
(169)
Medical Sciences
(159)
Aged
(149)
Oncology
(109)
Risk Factors
(107)
Public, Environmental & Occupational Health
(75)
Cohort Studies
(66)
Case-Control Studies
(64)
Prospective Studies
(64)
General & Internal Medicine
(62)
Mortality
(56)
Tumors
(49)
Medicin Och Hälsovetenskap
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial

Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapy

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

OC-0220 CHEMORADIOTHERAPY VS BIORADIOTHERAPY FOR LARYNX PRESERVATION: A GORTEC RANDOMIZED TRIAL (TREMPLIN)

Basaloid squamous cell carcinoma of the head and neck: report of 18 cases

Elderly head and neck cancer (elan) study: Personalized treatment according to geriatric assessment in patients age 70 or older: First (SCCHN) unsuitable for surgery

Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel

ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

Impact on autonomy of biweekly docetaxel as first-line chemotherapy (CT) regimen in elderly patients with metastatic breast cancer (MBC) – A FNCLCC Gerico Group Phase II multicentre trial

Doxorubin-based adjuvant chemotherapy for elderly patients with hormone receptors negative breast carcinoma: a French geriatric oncology group (GERICO) phase II multicentric program

Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness

1110O - Personalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials

Personalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials

1110OPersonalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

Apigenin – strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo

Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

8518 Prognostic value of the expression of SDF 1 and CXCR 4 in head and neck squamous cell carcinoma (HNSCC)

1331 Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): a feasibility study from the GEFCAPI

Traffic Accidents and Their Recurrenece in at Risk Adolescents and Young Adults : Realities and Perspectives

942TiPENCOURAGE: THE USE IN ROUTINE PRACTICE OF BEVACIZUMAB IN FIRST-LINE THERAPY FOR PATIENTS WITH OVARIAN CANCER– A GINECO PROSPECTIVE COHORT STUDY

Suchergebnisse filtern